Clorox (NYSE:CLX) Price Target Cut to $95.00 by Analysts at Wells Fargo & Company

Clorox (NYSE:CLX) had its target price decreased by equities research analysts at Wells Fargo & Company from $100.00 to $95.00 in a research note issued on Monday,MarketScreener reports. Wells Fargo & Company‘s price objective would suggest a potential upside of 2.74% from the company’s previous close.

Several other brokerages have also recently issued reports on CLX. Weiss Ratings upgraded Clorox from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Monday, April 13th. Barclays decreased their price target on shares of Clorox from $102.00 to $85.00 and set an “underweight” rating for the company in a research note on Friday, May 1st. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and set a $91.00 price target on shares of Clorox in a report on Friday, May 1st. Royal Bank Of Canada reduced their price objective on shares of Clorox from $132.00 to $127.00 and set a “sector perform” rating on the stock in a report on Thursday, April 9th. Finally, TD Cowen lifted their price objective on shares of Clorox from $98.00 to $111.00 and gave the stock a “hold” rating in a research report on Tuesday, March 31st. One research analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and five have issued a Sell rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Reduce” and an average price target of $103.40.

Clorox Trading Up 2.2%

Shares of NYSE CLX opened at $92.47 on Monday. The company has a current ratio of 0.84, a quick ratio of 0.65 and a debt-to-equity ratio of 27.03. The stock has a market capitalization of $11.18 billion, a PE ratio of 15.05, a PEG ratio of 0.47 and a beta of 0.59. Clorox has a twelve month low of $84.70 and a twelve month high of $136.69. The stock has a fifty day simple moving average of $101.99 and a 200-day simple moving average of $106.90.

Clorox (NYSE:CLX) last released its earnings results on Thursday, April 30th. The company reported $1.64 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.55 by $0.09. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The company had revenue of $1.67 billion for the quarter, compared to analyst estimates of $1.67 billion. During the same period in the prior year, the business earned $1.45 EPS. The firm’s quarterly revenue was up .1% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. On average, equities analysts forecast that Clorox will post 5.63 earnings per share for the current year.

Insider Transactions at Clorox

In other news, Director Pierre R. Breber acquired 5,000 shares of Clorox stock in a transaction that occurred on Tuesday, May 5th. The stock was purchased at an average price of $85.82 per share, for a total transaction of $429,100.00. Following the completion of the transaction, the director directly owned 18,000 shares in the company, valued at approximately $1,544,760. This trade represents a 38.46% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 0.63% of the stock is owned by corporate insiders.

Institutional Trading of Clorox

Several hedge funds have recently modified their holdings of the business. Norges Bank acquired a new position in Clorox during the fourth quarter worth $135,735,000. Van ECK Associates Corp boosted its position in shares of Clorox by 93.9% during the 3rd quarter. Van ECK Associates Corp now owns 2,709,972 shares of the company’s stock worth $334,139,000 after purchasing an additional 1,312,471 shares in the last quarter. Invesco Ltd. grew its stake in shares of Clorox by 22.1% during the 4th quarter. Invesco Ltd. now owns 4,880,341 shares of the company’s stock worth $492,085,000 after purchasing an additional 884,751 shares during the period. Northwestern Mutual Wealth Management Co. grew its stake in shares of Clorox by 6,907.9% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 749,703 shares of the company’s stock worth $75,593,000 after purchasing an additional 739,005 shares during the period. Finally, Worldquant Millennium Advisors LLC purchased a new position in shares of Clorox in the 2nd quarter valued at about $71,856,000. 78.53% of the stock is owned by institutional investors and hedge funds.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.